Agilent Technologies

490 articles with Agilent Technologies

• InterVenn Enters into Collaboration with Agilent Technologies on Clinical Glycoproteomic Analysis

  10/20/2020

  InterVenn has announced a collaboration with Agilent Technologies, a leading provider of bio-analytical and scientific instrumentation.

• Agilent to Showcase Their Commitment to Sustainability at analytica virtual 2020

  10/19/2020

  Agilent Technologies Inc. (NYSE: A) today announced that their 1220, 1260, and 1290 Infinity II LC product families have received the My Green Lab accountability, consistency, and transparency (ACT) certification. Recognition of these products by My Green Lab highlights Agilent's commitment to pursuing sustainability throughout the production and lifecycle

• Agilent Vaya Raman Raw Material ID Verification System Receives 2020 R&D 100 Award

  10/15/2020

  Agilent Technologies Inc. (NYSE: A) today announced that the Agilent Vaya Raman raw material identity verification system has received a 2020 R&D 100 Award in the Analytical/Test category. The worldwide competition, held by R&D World , recognizes R&D pioneers and their revolutionary contributions to science an

• Agilent Announces Cash Dividend of 18 Cents Per Share - Sep 16, 2020

  9/16/2020

  Agilent Technologies Inc. announced that a quarterly dividend of 18 cents per share of common stock will be paid on Oct. 28, 2020, to all shareholders of record as of the close of business on Oct. 6, 2020.

• Agilent Announces Webcast for Investment Community

  9/3/2020

  Agilent Technologies Inc. (NYSE: A) today announced the company will participate in the Wells Fargo 2020 Virtual Healthcare Conference on Wednesday, Sept. 9. A webcast of the event will be available for the investment community. The details: What: Wells Fargo 2020 Virtual Healthcare Conference When: Wednesday, Sept. 9 at 10:40 a.m. (EDT) Who: Bob McMahon, Agilent chief financial officer Wh

• Agilent Announces SureSelect XT HS2 RNA Reagent Kit, a Library Prep and Target Enrichment Solution for RNA-Seq

  9/1/2020

  Agilent Technologies Inc. (NYSE: A) today announced the release of the SureSelect XT HS2 RNA Reagent Kit . This solution features a modular design that enables a simple and parallel approach for both RNA and DNA samples, allowing customers to streamline and consolidate their workflow without losing time optimizing different kits for different s

• Agilent Sets the Standard in Customer Flexibility with Analytical Technology Subscription Model

  8/27/2020

  Agilent Technologies Inc. (NYSE: A) today announced its first-ever instrument subscription program, designed to meet the needs of customers with dynamic businesses who want the latest technology backed by the industry’s best service and support.

• Agilent to Expand State-of-the-Art Manufacturing Capacity for Nucleic Acid-Based Therapeutics

  8/18/2020

  Agilent Technologies Inc. (NYSE: A) today announced it will expand its state-of-the-art production facility in Frederick, Colorado, that develops and manufactures “oligos,” which are short DNA and RNA molecules used to create nucleic acid-based therapeutics.

• Intabio Signs Co-Marketing Agreement with Agilent Technologies Inc. to Support Development of Integrated iCIEF-MS Assay

  8/11/2020

  Intabio, Inc., a developer of analytical solutions that provide profound efficiency gains across all stages of biopharmaceutical development and manufacturing, today announces a co-marketing and equipment loan agreement with Agilent Technologies Inc. to support development of integrated iCIEF-MS assays by interfacing Intabio's Blaze

• Agilent Technologies Announces Proposed Offering of Senior Notes - Jun 01, 2020

  6/1/2020

  Agilent Technologies Inc. announced it is offering, subject to market and other conditions, a series of senior notes under an automatic shelf registration statement on file with the Securities and Exchange Commission.

• Agilent Technologies Announces Pricing of $500 Million of Senior Notes - Jun 01, 2020

  6/1/2020

  Agilent Technologies, Inc. announced the pricing of an underwritten, registered public offering of a series of its senior notes in an aggregate principal amount of $500 million.

• Agilent Announces New Mass Spectrometry Products at ASMS 2020 Reboot

  6/1/2020

  Agilent Technologies Inc. (NYSE: A) today announced two new mass spectrometry (MS) products: the Agilent 6470B Triple Quadrupole LC/MS (6470 LC/TQ) system, and the Agilent RapidFire 400 system. Both deliver even faster detection of target compounds providing customers increased sample throughput and reduc

• Agilent to Present at Jefferies Virtual Healthcare Conference

  5/27/2020

  Agilent Technologies Inc. (NYSE: A) today announced the following webcast for the investment community.

• Agilent Technologies Reports First Quarter Fiscal Year 2020 Financial Results

  2/18/2020

  Agilent Technologies Inc. reported revenue of $1.36 billion for the first quarter ended Jan. 31, 2020, up 5.7% year over year.

• 

  Twist Settles Legal Battle With $22.5 Million Payment, No Admission of Wrongdoing

  2/7/2020

  A four-year-old legal battle between Agilent Technologies and Twist Bioscience came to a conclusion Thursday. Twist agreed to pay Agilent $22.5 million to settle the lawsuit filed in 2016.

• Biofidelity and Agilent complete successful molecular assay study for rapid and accurate detection of key lung cancer mutations

  1/9/2020

  Biofidelity assay has potential to make high precision, cost-effective and non-invasive diagnosis more widely available, improving treatment and patient outcomes

• 

  Top 10 Gene Sequencing Companies by Revenue

  11/29/2019

  The gene sequencing industry has really taken off in the years since the Human Genome Project’s rough draft was announced in June 2000.

• High-performance Liquid Chromatography (HPLC) Market 2019-2023 | Evolving Opportunities with Agilent Technologies, Inc. and GE Healthcare | Technavio

  10/10/2019

  Technavio has been monitoring the global high-performance liquid chromatography market since 2016 and the market is poised to grow by USD 1.05 billion during 2019-2023, progressing at a CAGR of almost 5% during the forecast period.

• Agilent Named Industry Leader in 2019 Dow Jones Sustainability Index

  10/3/2019

  Achieves industry leadership recognition in DJSI’s Life Sciences Tools and Services category for fifth consecutive year

• Agilent to Acquire BioTek, Strengthening Leadership Position in Growing Cell Analysis Segment

  7/11/2019

  Combined portfolio enables Agilent to provide a more complete and integrated solution for customers in the important and fast-growing area of live cell analysis